228 related articles for article (PubMed ID: 34563208)
21. Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.
Guedea F; Ferrer M; Pera J; Aguiló F; Boladeras A; Suárez JF; Cunillera O; Ferrer F; Pardo Y; Martínez E; Ventura M
Clin Transl Oncol; 2009 Jul; 11(7):470-8. PubMed ID: 19574206
[TBL] [Abstract][Full Text] [Related]
22. Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index.
Gacci M; Livi L; Paiar F; Detti B; Litwin MS; Bartoletti R; Giubilei G; Cai T; Mariani M; Carini M
Urology; 2005 Aug; 66(2):338-43. PubMed ID: 16098363
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the quality of life of patients with localizad prostate cancer: validation of the Spanish version of the EPIC].
Ferrer M; Garin O; Pera J; Prats JM; Mendivil J; Alonso J; De Paula B; Herruzo I; Hervas A; Macias V; Mariño A; Ortiz MJ; Pastor S; Ponce De León J; Sancho G;
Med Clin (Barc); 2009 Feb; 132(4):128-35. PubMed ID: 19211071
[TBL] [Abstract][Full Text] [Related]
24. Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy.
Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
Jpn J Clin Oncol; 2009 Aug; 39(8):502-8. PubMed ID: 19477898
[TBL] [Abstract][Full Text] [Related]
25. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer.
Litwin MS; Gore JL; Kwan L; Brandeis JM; Lee SP; Withers HR; Reiter RE
Cancer; 2007 Jun; 109(11):2239-47. PubMed ID: 17455209
[TBL] [Abstract][Full Text] [Related]
26. Health-related Quality of Life and Toxicity After Single-fraction High-dose-rate Brachytherapy With External Beam Radiotherapy for Localized and Locally Advanced Prostate Cancer.
Makino T; Nakashima K; Iijima M; Kawaguchi S; Nohara T; Shigehara K; Izumi K; Kadono Y; Kumano T; Mizokami A
Anticancer Res; 2019 Jan; 39(1):477-486. PubMed ID: 30591498
[TBL] [Abstract][Full Text] [Related]
27. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
[TBL] [Abstract][Full Text] [Related]
28. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
[TBL] [Abstract][Full Text] [Related]
29. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
30. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.
Litwin MS; Hays RD; Fink A; Ganz PA; Leake B; Brook RH
Med Care; 1998 Jul; 36(7):1002-12. PubMed ID: 9674618
[TBL] [Abstract][Full Text] [Related]
31. Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (<60 cc) and large (≥60 cc) prostate glands.
Press RH; Morgan TM; Cutrell PK; Zhang C; Chen Z; Rahnema S; Sanda M; Pattaras J; Patel P; Jani AB; Rossi PJ
Brachytherapy; 2019; 18(1):13-21. PubMed ID: 30262410
[TBL] [Abstract][Full Text] [Related]
32. Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations.
Axcrona K; Nilsson R; Brennhovd B; Sørebø Ø; Fosså SD; Dahl AA
BMC Urol; 2017 Dec; 17(1):111. PubMed ID: 29197360
[TBL] [Abstract][Full Text] [Related]
33. Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.
Lee JY; Daignault-Newton S; Heath G; Scarlett S; Sanda MG; Chang P; Regan MM; Michalski JM; Sandler HM; Feng FY; Kuban DA; Zietman AL; Ciezki JP; Kaplan ID; Crociani C; McLaughlin WP; Mantz CA; Finkelstein SE; Suy S; Collins SP; Garin O; Ferrer M; Hamstra DA; Spratt DE
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):770-777. PubMed ID: 27663760
[TBL] [Abstract][Full Text] [Related]
34. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
35. Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the Expanded Prostate Cancer Index Composite.
Kakehi Y; Takegami M; Suzukamo Y; Namiki S; Arai Y; Kamoto T; Ogawa O; Fukuhara S
J Urol; 2007 May; 177(5):1856-61. PubMed ID: 17437836
[TBL] [Abstract][Full Text] [Related]
36. Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification.
Takizawa I; Hara N; Nishiyama T; Kaneko M; Hoshii T; Tsuchida E; Takahashi K
Asian J Androl; 2009 May; 11(3):283-90. PubMed ID: 19349948
[TBL] [Abstract][Full Text] [Related]
37. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
Downs TM; Sadetsky N; Pasta DJ; Grossfeld GD; Kane CJ; Mehta SS; Carroll PR; Lubeck DP
J Urol; 2003 Nov; 170(5):1822-7. PubMed ID: 14532784
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life for men with prostate cancer--an evaluation of outcomes 12-24 months after treatment.
Brassell SA; Elsamanoudi SI; Cullen J; Williams ME; McLeod DG
Urol Oncol; 2013 Nov; 31(8):1504-10. PubMed ID: 22608541
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal Changes in Health-related Quality of Life After
Ogasawara N; Nakiri M; Kurose H; Ueda K; Chikui K; Nishihara K; Matsuo M; Suekane S; Murotani K; Muraki K; Hattori C; Ogo E; Igawa T; Ishitake T
Anticancer Res; 2020 Nov; 40(11):6443-6456. PubMed ID: 33109583
[TBL] [Abstract][Full Text] [Related]
40. Estimating preferences for treatments in patients with localized prostate cancer.
Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
